Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Sonata Therapeutics and the Champalimaud Foundation Announce Joint Research Effort for SNT-3012 Targeting Pancreatic and Colorectal Cancers
Wednesday, March 06, 2024Sonata Therapeutics a biotechnology company specializing in the development of a novel category of treatments known as Network Medicines has announced a collaboration with the Champalimaud
AnHeart Therapeutics and Innovent Announce China's NMPA Acceptance of Second New Drug Application for Taletrectinib in First-Line Treatment of ROS1-Positive Lung Cancer
Tuesday, March 05, 2024AnHeart Therapeutics a global biopharmaceutical company specializing in precision cancer therapies and Innovent Biologics Inc a leading biopharmaceutical firm focusing on oncology and other major diseases
FDA Approves Clobetasol Propionate Ophthalmic Suspension for Post-Operative Pain after Ocular Surgery
Tuesday, March 05, 2024Today Formosa Pharmaceuticals headquartered in Taiwan in partnership with AimMax Therapeutics based in the United States announced a significant milestone the US Food and Drug Administration
Medigene Expands Patent Portfolio in Japan for iM-TCR Technology Enhancing TCR-T Safety and Efficacy
Tuesday, March 05, 2024Medigene AG has recently received a patent from the Japan Patent Office for its inducible Medigene T cell receptor a mechanism designed to regulate the efficacy and safety of its T cell receptor engineered T cell
C4 Therapeutics and Merck KGaA, Darmstadt, Germany, Team Up in Strategic Discovery Collaboration Against Critical Oncogenic Proteins
Monday, March 04, 2024C Therapeutics Inc has announced a collaboration with Merck KGaA Darmstadt Germany operating as EMD Serono in the US and Canada to develop two targeted protein degraders
Jacobio Pharma Secures IND Approval for P53 Y220C Activator JAB-30300 in the U.S.
Saturday, March 02, 2024Jacobio Pharma a clinicalstage oncology company focusing on targeting challenging drug sites has disclosed that the FDA has granted approval for its Investigational New Drug application concerning JAB
SciSparc Launches Clinical Trial for Autism Spectrum Disorder Treatment, Commencing Dosing Phase
Friday, March 01, 2024SciSparc Ltd a specialized clinicalstage pharmaceutical firm focusing on therapies for central nervous system disorders and rare diseases has reported the successful manufacturing and delivery of its
Cardiff Oncology Initiates Randomized Trial for First-Line RAS-Mutated Metastatic Colorectal Cancer Treatment (CRDF-004)
Friday, March 01, 2024Cardiff Oncology Inc a biotech company specializing in developing new therapies for various cancers using PLK inhibition has announced the dosing of the first patient in its randomized Phase trial
Recce Pharmaceuticals and Murdoch Children’s Research Institute Extend Collaborative Partnership
Friday, March 01, 2024Recce Pharmaceuticals Ltd has announced the ongoing progress of its AntiInfective Research Unit at the Murdoch Childrens Research Institute aimed at enhancing its preclinical programs and exploring
BioLineRx Initiates First Patient Dosing in Randomized Phase 2 Combination Clinical Trial for Motixafortide in First-Line Pancreatic Cancer (PDAC)
Thursday, February 29, 2024BioLineRx Ltd has initiated the randomized CheMoMETPANC Phase combination clinical trial representing a crucial advancement in its efforts to develop groundbreaking therapies
